[go: up one dir, main page]

BRPI0808856B8 - soluções antimicrobianas contendo monóxido de dicloro, seus processos de preparação e método não terapêutico para desinfetar uma superfície - Google Patents

soluções antimicrobianas contendo monóxido de dicloro, seus processos de preparação e método não terapêutico para desinfetar uma superfície

Info

Publication number
BRPI0808856B8
BRPI0808856B8 BRPI0808856A BRPI0808856A BRPI0808856B8 BR PI0808856 B8 BRPI0808856 B8 BR PI0808856B8 BR PI0808856 A BRPI0808856 A BR PI0808856A BR PI0808856 A BRPI0808856 A BR PI0808856A BR PI0808856 B8 BRPI0808856 B8 BR PI0808856B8
Authority
BR
Brazil
Prior art keywords
disinfecting
solutions containing
therapeutic method
preparation processes
dichlorine monoxide
Prior art date
Application number
BRPI0808856A
Other languages
English (en)
Inventor
Northey Robert
Original Assignee
Oculus Innovative Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oculus Innovative Sciences Inc filed Critical Oculus Innovative Sciences Inc
Publication of BRPI0808856A2 publication Critical patent/BRPI0808856A2/pt
Publication of BRPI0808856B1 publication Critical patent/BRPI0808856B1/pt
Publication of BRPI0808856B8 publication Critical patent/BRPI0808856B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

soluções antimicrobianas contendo monóxido de dicloro e métodos de fabricação e uso das mesmas a presente invenção refere-se a métodos e produtos que são providos para tratamento de uma ferida ou infecção em um mamífero ou desinfecção de uma superfície com uma solução de ácido hipocloroso que foi ativada por um catalisador. é ainda provido um processo para preparação de um produto antimicrobiano que produz uma solução de ácido hipocloroso ativada para uso como um antimicrobiano.
BRPI0808856A 2007-03-13 2008-03-13 soluções antimicrobianas contendo monóxido de dicloro, seus processos de preparação e método não terapêutico para desinfetar uma superfície BRPI0808856B8 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90693907P 2007-03-13 2007-03-13
US60/906,939 2007-03-13
US60/906,936 2007-03-13
PCT/US2008/056919 WO2008112940A1 (en) 2007-03-13 2008-03-13 Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same

Publications (3)

Publication Number Publication Date
BRPI0808856A2 BRPI0808856A2 (pt) 2014-09-09
BRPI0808856B1 BRPI0808856B1 (pt) 2021-01-19
BRPI0808856B8 true BRPI0808856B8 (pt) 2021-05-25

Family

ID=39491366

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0808856A BRPI0808856B8 (pt) 2007-03-13 2008-03-13 soluções antimicrobianas contendo monóxido de dicloro, seus processos de preparação e método não terapêutico para desinfetar uma superfície

Country Status (10)

Country Link
US (3) US8784900B2 (pt)
EP (1) EP2136819A1 (pt)
JP (1) JP6099294B2 (pt)
KR (1) KR101569134B1 (pt)
CN (1) CN101932330B (pt)
AU (1) AU2008224968B2 (pt)
BR (1) BRPI0808856B8 (pt)
CA (1) CA2680483C (pt)
MX (1) MX2009009760A (pt)
WO (1) WO2008112940A1 (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2602411C (en) 2005-03-23 2015-02-24 Oculus Innovative Sciences, Inc. Method of treating second and third degree burns using oxidative reductive potential water solution
JP5723084B2 (ja) 2006-01-20 2015-05-27 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 酸化還元電位水溶液を用いた副鼻腔炎の予防または治療方法
US8877257B2 (en) 2007-01-16 2014-11-04 Puricore, Inc. Methods and compositions for treating conditions associated with infection and/or inflammation
US9999635B2 (en) 2007-01-16 2018-06-19 Realm Therapeutics, Inc. Methods and compositions for treating inflammatory disorders
US8784900B2 (en) * 2007-03-13 2014-07-22 Oculus Innovative Sciences, Inc. Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same
WO2010075477A2 (en) * 2008-12-22 2010-07-01 Oculus Innovative Sciences, Inc. Methods of treating or preventing biofilm associated infections with free available chlorine water
US10342825B2 (en) 2009-06-15 2019-07-09 Sonoma Pharmaceuticals, Inc. Solution containing hypochlorous acid and methods of using same
US8785713B2 (en) * 2010-04-13 2014-07-22 Kci Licensing, Inc. Compositions with reactive ingredients, and wound dressings, apparatuses, and methods
WO2012129161A2 (en) 2011-03-18 2012-09-27 Puricore, Inc. Stabilized hypohalous acid solutions
US11452778B2 (en) 2011-03-18 2022-09-27 Urgo Us, Inc. Stabilized hypohalous acid solutions
US9381214B2 (en) 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
US8882972B2 (en) 2011-07-19 2014-11-11 Ecolab Usa Inc Support of ion exchange membranes
US9669041B2 (en) 2011-10-27 2017-06-06 Novan, Inc. Nitric oxide releasing bath compositions and methods of using the same
US11357794B2 (en) 2012-02-17 2022-06-14 Wiab Wafer Innovation Ab Preparations for controlled-release of hypochlorous acid
EP2814776B1 (en) * 2012-02-17 2018-04-11 Wiab Water Innovation AB Compositions of hypochlorous acid (hoci) and methods of manufacture thereof
US12115185B2 (en) 2012-02-17 2024-10-15 Wiab Water Innovation Ab Compositions of hypochlorous acid and methods of manufacture thereof
US10675299B2 (en) 2012-02-17 2020-06-09 Wiab Water Innovation Ab Hand disinfectant
US11672825B2 (en) 2012-02-17 2023-06-13 Wiab Water Innovation Ab Acetic acid and hypochlorous acid compositions for treatment of biofilms and wound care
US11364262B2 (en) 2012-02-17 2022-06-21 Wiab Water Innovation Ab Acetic acid and hypochlorous acid compositions for treatment of skin trauma
US11484549B2 (en) 2012-02-17 2022-11-01 Wiab Water Innovation Ab Compositions and methods for treating biofilms without inducing antimicrobial resistance
US11364263B2 (en) * 2012-02-17 2022-06-21 Wiab Wafer Innovation Ab Compositions and methods for aerodigestive treatment
US11478507B2 (en) 2012-02-17 2022-10-25 Wiab Water Innovation Ab Compositions and methods for treating biofilms
US11452741B2 (en) 2012-02-17 2022-09-27 Wiab Water Innovation Ab Compositions and methods for treating transient biofilms
MX373524B (es) 2013-05-22 2020-04-21 Sanfer Farma S A P I De C V Solución estabilizada de ácido hipocloroso y uso de la misma.
US20150099010A1 (en) 2013-10-07 2015-04-09 Reoxcyn Discoveries Group, Inc Redox signaling gel formulation
US20150125543A1 (en) * 2013-11-07 2015-05-07 Simple Science Limited Gel disinfecting composition
GB2532070B (en) 2014-11-07 2018-05-09 Xanadox Tech Limited Improvements relating to hypochlorous acid solutions
CH710357A1 (de) * 2014-11-11 2016-05-13 Bogaert Jean-Pierre Kosmetisches und pharmazeutisches Mittel zur Behandlung von Hautrissen.
WO2016126855A1 (en) 2015-02-03 2016-08-11 Tipul Biotechnology, LLC Devices and methods for electrolytic production of disinfectant solution from salt solution in a container
US10485827B2 (en) 2016-01-19 2019-11-26 Rdg Holdings, Inc. Topical eye serum compositions, methods or preparing, and methods of use
US10897905B2 (en) 2016-01-26 2021-01-26 Metrex Research, LLC Hypochlorite based hard surface disinfectants
CN105622619A (zh) * 2016-03-07 2016-06-01 郑海英 一种治疗牙周炎的药物组合物
ITUA20161673A1 (it) * 2016-03-15 2017-09-15 Danilo Coral Uso di una formulazione farmaceutica in ambito medico umano veterinario e sanitario. la formulazione prevede l' utilizzo di ipoclorito dibasico di magnesio in ambiente acido
US11857674B2 (en) 2016-05-18 2024-01-02 Reoxcyn, Llc Lubricant formulations
US9474768B1 (en) 2016-05-18 2016-10-25 Reoxcyn Discoveries Group, Inc. Lubricant formulations
US9833471B1 (en) 2016-09-15 2017-12-05 Reoxcyn Discoveries Group, Inc. Hypochlorous acid-based hand sanitizer
US20180200165A1 (en) 2017-01-16 2018-07-19 Reoxcyn Innovation Group, Llc Dentifrice formulations and methods of oral care
CA3067855A1 (en) 2017-06-28 2019-01-03 Collidion, Inc. Compositions, methods and uses for cleaning, disinfecting and/or sterilizing
WO2019140408A1 (en) 2018-01-14 2019-07-18 Collidion, Inc. Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating
WO2020041631A1 (en) 2018-08-22 2020-02-27 Avalyn Pharma Inc. Specially formulated compositions of inhaled nintedanib and nintedanib salts
US10986841B2 (en) 2018-11-06 2021-04-27 The Clorox Company Bleach compositions
EP3927351A4 (en) * 2019-02-20 2023-01-04 Biiosmart Technologies LLC INTRAVENOUS HYPOCHLOROUS ACID SOLUTION, PREPARATION AND METHOD OF USE THEREOF
KR20220054575A (ko) 2019-06-14 2022-05-03 콜리디온, 인코포레이티드 미생물 생장을 방지하기 위한 조성물, 키트, 방법 및 용도
CN110367277A (zh) * 2019-07-25 2019-10-25 江苏申苏环境科技有限公司 一种弱酸性次氯酸消毒液的制备及其使用方法
JP7497790B2 (ja) * 2019-12-27 2024-06-11 国立大学法人北海道大学 豚コレラの治療及び／又は予防剤
US11845916B2 (en) 2020-06-24 2023-12-19 The Clorox Company Burstable sporicidal cleaning wipe system containing stabilized hypochlorite
KR20230145023A (ko) * 2020-07-07 2023-10-17 더블유아이에이비 워터 이노베이션 에이비 미생물 감염을 소독, 치료 및 예방하기 위한 조성물 및 방법
US11957711B2 (en) * 2021-02-27 2024-04-16 Reinaldo Foget Mora Fogonazo solution
CN113274558A (zh) * 2021-05-21 2021-08-20 江苏松德生物科技有限公司 一种用于洗肾的血液透析医用导管及其制备方法
CN115947442B (zh) * 2021-10-08 2025-02-18 香港科技大学 在高氯水环境中原位形成一氧化二氯的方法
WO2024085926A2 (en) * 2022-06-30 2024-04-25 University Of Utah Research Foundation Compositions and methods of treating, preventing or inhibiting a facultative anaerobe infection

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US742A (en) * 1838-05-17 Perigrine williamson
US4146578A (en) * 1977-12-27 1979-03-27 Olin Corporation Hypochlorous acid process
US4190638A (en) * 1978-06-07 1980-02-26 Ppg Industries, Inc. Production of hypochlorous acid
DE3046324A1 (de) 1980-12-09 1982-12-16 Rudolf Dr.med. 6900 Heidelberg Anderson Verfahren zur herstellung eines praeparates zur vernichtung von mikroben, welche die lunge befallen
CN1006888B (zh) * 1985-09-19 1990-02-21 拜尔公司 制备2，4-二氯-5-氟-苯甲酸的方法
US5037627A (en) * 1988-10-31 1991-08-06 Olin Corporation Hypochlorous acid process
US5152915A (en) * 1991-09-03 1992-10-06 Olin Corporation Recovery of dichlorine monoxide from hypochlorous acid solutions
US5888528A (en) * 1997-05-19 1999-03-30 Bernard Technologies, Inc. Sustained release biocidal powders
RO117540B1 (ro) 1997-06-13 2002-04-30 Scchimcomplex Sa Borzesti Compozitie dezinfectanta-detergenta
GB2355190B (en) * 1999-08-23 2004-07-28 Sterilox Medical Improvements in or relating to sterilising preparations
US7323118B2 (en) * 2001-10-01 2008-01-29 Aquilabs S.A. Composition of hypochlorous acid and its applications
CN1802312A (zh) * 2003-05-12 2006-07-12 约翰逊迪瓦西公司 制备和分配二氧化氯
US20040226894A1 (en) * 2003-05-12 2004-11-18 Tatsuo Okazaki Method of preparing a sterile water containing hypochlorous or chlorous acid, package of sterile source materials, and sterile water preparation kit
US7592300B2 (en) 2003-11-24 2009-09-22 The Dial Corporation Antimicrobial compositions containing an aromatic carboxylic acid and a hydric solvent
US20050175579A1 (en) 2004-02-10 2005-08-11 Koganov Michael M. Methods and compositions for the treatment of inflammation
RU2006133386A (ru) 2004-02-19 2008-03-27 Рекитт Энд Колмэн (Оуверсиз) Лимитед (Gb) Композиции по уходу за кожей, содержащие салициловую кислоту
US7383946B2 (en) * 2004-03-26 2008-06-10 Hughes Kenneth D Materials for storing and releasing reactive gases
US7758807B2 (en) * 2004-04-20 2010-07-20 The Clorox Company Microbial control with reduced chlorine
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
US8784900B2 (en) * 2007-03-13 2014-07-22 Oculus Innovative Sciences, Inc. Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same

Also Published As

Publication number Publication date
BRPI0808856B1 (pt) 2021-01-19
CA2680483C (en) 2017-12-12
AU2008224968A1 (en) 2008-09-18
US20140328946A1 (en) 2014-11-06
CA2680483A1 (en) 2008-09-18
US8784900B2 (en) 2014-07-22
JP6099294B2 (ja) 2017-03-22
KR101569134B1 (ko) 2015-11-13
AU2008224968B2 (en) 2013-08-22
CN101932330A (zh) 2010-12-29
US9486479B2 (en) 2016-11-08
KR20100014589A (ko) 2010-02-10
WO2008112940A1 (en) 2008-09-18
US20170049813A1 (en) 2017-02-23
BRPI0808856A2 (pt) 2014-09-09
US20100112092A1 (en) 2010-05-06
CN101932330B (zh) 2015-01-14
EP2136819A1 (en) 2009-12-30
JP2010521489A (ja) 2010-06-24
MX2009009760A (es) 2009-09-24

Similar Documents

Publication Publication Date Title
BRPI0808856B8 (pt) soluções antimicrobianas contendo monóxido de dicloro, seus processos de preparação e método não terapêutico para desinfetar uma superfície
CY1125130T1 (el) Ανταγωνιστες c5ar
BR112012010270A2 (pt) mentisulfonilmetano (msm) para tratamento de micro-organismos resistentes a fármaco
CL2013002599A1 (es) Composición que comprende una solución de ácido hipocloroso (hocl); proceso para preparar solución acuosa de hocl; uso como agente antimicrobiano, como agente de limpieza o esterilizador; material impregnado con la composición y uso para esterilizar objetos.
CU20130063A7 (es) Proceso de producción de depsipéptidos cíclicos
BRPI1011886A8 (pt) Solução contendo ácido hiplocloroso e métodos do uso do mesmo.
AR062148A1 (es) Proceso quimico para la preparacion de intermediarios
BR112014007193A2 (pt) derivados de pirazoloquinolinona, preparação dos mesmos e uso terapêutico dos mesmos
BR112013000107A2 (pt) aminopirazoloquinazolinas
CL2009000879A1 (es) Metodo para fabricar un producto en un biorreactor que comprende cultivar microorganismos que son adaptados o mutagenizados para que exhiban por lo menos un 150% de tolerancia al producto; sistema para fabricar un producto; biorreactor.
TN2009000132A1 (en) Substituted dihydropyrazolones for treating cardiovascular and haematological diseases
MX2014001717A (es) Composiciones inmunoterapeuticas de levadura-mucina 1 (muc1) y usos de las mismas.
BR112014029967A2 (pt) leitos para animais com baixo teor de poeira e métodos para fabricação dos mesmos
ATE435667T1 (de) Mit polykationen oberflächenbehandeltes wasserabsorbierende polymergebilde
BR112013031307A2 (pt) métodos para tratamento de material lignocelulósico
BR112014016185A2 (pt) processo para a produção de uma mistura de ácido 2,4-furandicarboxílico e ácido 2,5-furandicarboxílico (fdca) por meio de reação de dismutação, mistura de 2,4-fdca e 2,5-fdca obtenível por meio desta, 2,4-fdca obtenível por meio desta e uso de 2,4-fdca
BR112015006393A2 (pt) método para produzir um produto de tecido, produto de tecido produzido por um processo, e método de tratamento
WO2015061632A3 (en) Antimicrobial compositions and articles
BR112014031051A2 (pt) processo para produção de uma composição contendo folistatina ativa
BR112013010698A2 (pt) processo para o tratamento de água contaminada por meio de adsorção e nanofiltração
BR112013001344A2 (pt) partículas de liberação com uma pluralidade de núcleos
BR112015002464B8 (pt) processo para a preparação de carbamat-benzoxazinona, carbamat-benzoxazinona e uso da carbamat-benzoxazinona
CR20120082A (es) Conservantes de derivados de quitina
BR112012020404A2 (pt) epimerização de sacarídeos.
AU2013288664B2 (en) Dressing having the controlled release of active agents

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/01/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/03/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25A Requested transfer of rights approved

Owner name: INVEKRA, S.A.P.I DE C.V. (MX)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: OCULUS INNOVATIVE SCIENCES, INC. (US)

Free format text: ANULADA A PUBLICACAO CODIGO 25.1 NA RPI NO 2637 DE 20/07/2021 POR TER SIDO INDEVIDA.

B25A Requested transfer of rights approved

Owner name: INVEKRA, S.A.P.I DE C.V. (MX)

B25D Requested change of name of applicant approved

Owner name: SANFER FARMA, S.A.P.I DE C.V. (MX)